Cargando…
Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report
BACKGROUND: Given the current climate of the pandemic, lung cancer patients are especially vulnerable to complications from severe acute respiratory syndrome coronavirus 2 infection. As a high-risk population group, these patients are strongly advised to receive coronavirus disease 2019 vaccination...
Autores principales: | Tripathy, Shreya, Alvarez, Nathaniel, Jaiswal, Shubham, Williams, Ryan, Al-Khadimi, Munaf, Hackman, Sarah, Phillips, William, Kaur, Supreet, Cervantez, Sherri, Kelly, William, Taverna, Josephine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700935/ https://www.ncbi.nlm.nih.gov/pubmed/36434709 http://dx.doi.org/10.1186/s13256-022-03660-9 |
Ejemplares similares
-
Targeting fat browning in hypermetabolic conditions: a clinical perspective
por: Kaur, Supreet, et al.
Publicado: (2020) -
Lung mass with bilateral mediastinal hypermetabolic lymphadenopathy in a chronic smoker indicative of lung cancer?
por: Ali, Asghar, et al.
Publicado: (2019) -
Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID‐19 vaccination: A mimicker of disease progression in Hodgkin lymphoma
por: Suleman, Adam, et al.
Publicado: (2021) -
The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Patients Management
por: Ferrari, Cristina, et al.
Publicado: (2021) -
Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
por: Thaweerat, Wajana
Publicado: (2022)